Brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma (HL): North American results. Ramchandren, R., Advani, R. H., Ansell, S. M., Bartlett, N. L., Chen, R. W., Feldman, T., Forero-Torres, A., Friedberg, J. W., Gopal, A. K., Gordon, L. I., Kuruvilla, J., Savage, K. J., Straus, D. J., Younes, A., Fenton, K., Manley, T., Engley, G., Connors, J. M. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.7541

View details for Web of Science ID 000442916003007